201 related articles for article (PubMed ID: 36574676)
1. Bioprosthetic heart valve structural degeneration associated with metabolic syndrome: Mitigation with polyoxazoline modification.
Abramov A; Xue Y; Zakharchenko A; Kurade M; Soni RK; Levy RJ; Ferrari G
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2219054120. PubMed ID: 36574676
[TBL] [Abstract][Full Text] [Related]
2. Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes.
Xue Y; Kossar AP; Abramov A; Frasca A; Sun M; Zyablitskaya M; Paik D; Kalfa D; Della Barbera M; Thiene G; Kozaki S; Kawashima T; Gorman JH; Gorman RC; Gillespie MJ; Carreon CK; Sanders SP; Levy RJ; Ferrari G
Cardiovasc Res; 2023 Mar; 119(1):302-315. PubMed ID: 35020813
[TBL] [Abstract][Full Text] [Related]
3. Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction.
Lee S; Levy RJ; Christian AJ; Hazen SL; Frick NE; Lai EK; Grau JB; Bavaria JE; Ferrari G
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28483776
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of advanced glycation end product formation and serum protein infiltration in bioprosthetic heart valve leaflets: Investigations of anti-glycation agents and anticalcification interactions with ethanol pretreatment.
Zakharchenko A; Rock CA; Thomas TE; Keeney S; Hall EJ; Takano H; Krieger AM; Ferrari G; Levy RJ
Biomaterials; 2022 Oct; 289():121782. PubMed ID: 36099713
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
[TBL] [Abstract][Full Text] [Related]
6. A PEGylation method of fabricating bioprosthetic heart valves based on glutaraldehyde and 2-amino-4-pentenoic acid co-crosslinking with improved antithrombogenicity and cytocompatibility.
Ding K; Zheng C; Huang X; Zhang S; Li M; Lei Y; Wang Y
Acta Biomater; 2022 May; 144():279-291. PubMed ID: 35365404
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure.
Kostyunin AE; Glushkova TV; Lobov AA; Ovcharenko EA; Zainullina BR; Bogdanov LA; Shishkova DK; Markova VE; Asanov MA; Mukhamadiyarov RA; Velikanova EA; Akentyeva TN; Rezvova MA; Stasev AN; Evtushenko AV; Barbarash LS; Kutikhin AG
J Am Heart Assoc; 2023 Jan; 12(1):e028215. PubMed ID: 36565196
[TBL] [Abstract][Full Text] [Related]
8. Dual-crosslinked bioprosthetic heart valves prepared by glutaraldehyde crosslinked pericardium and poly-2-hydroxyethyl methacrylate exhibited improved antithrombogenicity and anticalcification properties.
Huang X; Zheng C; Ding K; Zhang S; Lei Y; Wei Q; Yang L; Wang Y
Acta Biomater; 2022 Dec; 154():244-258. PubMed ID: 36306983
[TBL] [Abstract][Full Text] [Related]
9. Studying Xenograft Rejection of Bioprosthetic Heart Valves.
Manji RA; Manji JS
Methods Mol Biol; 2020; 2110():227-243. PubMed ID: 32002912
[TBL] [Abstract][Full Text] [Related]
10. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties.
Yu T; Pu H; Chen X; Kong Q; Chen C; Li G; Jiang Q; Wang Y
Acta Biomater; 2023 Apr; 160():45-58. PubMed ID: 36764592
[TBL] [Abstract][Full Text] [Related]
11. Degeneration of Bioprosthetic Heart Valves: Update 2020.
Kostyunin AE; Yuzhalin AE; Rezvova MA; Ovcharenko EA; Glushkova TV; Kutikhin AG
J Am Heart Assoc; 2020 Oct; 9(19):e018506. PubMed ID: 32954917
[TBL] [Abstract][Full Text] [Related]
12. A systematic review on durability and structural valve deterioration in TAVR and surgical AVR.
Okutucu S; Niazi AK; Oliveira D; Fatihoglu SG; Oto A
Acta Cardiol; 2021 Nov; 76(9):921-932. PubMed ID: 33302806
[TBL] [Abstract][Full Text] [Related]
13. Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration.
Marro M; Kossar AP; Xue Y; Frasca A; Levy RJ; Ferrari G
J Am Heart Assoc; 2021 Feb; 10(3):e018921. PubMed ID: 33494616
[TBL] [Abstract][Full Text] [Related]
14. Review of bioprosthetic structural valve deterioration: Patient or valve?
Tnay TD; Shell D; Lui A
J Card Surg; 2022 Dec; 37(12):5243-5253. PubMed ID: 36317394
[TBL] [Abstract][Full Text] [Related]
15. Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves.
McGregor C; Byrne G; Rahmani B; Chisari E; Kyriakopoulou K; Burriesci G
Acta Biomater; 2016 Sep; 41():204-209. PubMed ID: 27268480
[TBL] [Abstract][Full Text] [Related]
16. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
[TBL] [Abstract][Full Text] [Related]
17. The role of echocardiography in the management of structural valve degeneration of transcatheter valves.
Shabadi R; Desai P; Al-Kemyani N; Al-Lawati H
Ann Card Anaesth; 2022; 25(1):89-92. PubMed ID: 35075028
[TBL] [Abstract][Full Text] [Related]
18. Durability of Bioprosthetic Valves in Patients on Dialysis.
Uzuka T; Nakamura M; Sugiyama H; Kondo M; Sakata J
Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):334-341. PubMed ID: 35545525
[TBL] [Abstract][Full Text] [Related]
19. Subclinical Structural Valve Degeneration in Young Patients With Bioprosthetic Aortic Valves.
Percy ED; Harloff M; Hirji S; Malarczyk A; Cherkasky O; Yazdchi F; McGurk S; Shekar P; Kaneko T
Ann Thorac Surg; 2021 May; 111(5):1486-1493. PubMed ID: 32979371
[TBL] [Abstract][Full Text] [Related]
20. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
